Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis

OBJECTIVE: Soluble Tumor Necrosis Factor Receptor II (sTNFR2) is used as a biomarker to study cardiovascular disease (CVD) in diverse populations. TNF inhibitors (TNFi's) are a common treatment for inflammatory conditions. The objective of this study was to examine whether TNFi use impacts meas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pract Lab Med
Hlavní autoři: Yang, Nicole, Huang, Jie, Frits, Michelle, Iannaccone, Christine, Weinblatt, Michael E., Rifai, Nader, Shadick, Nancy, Bradwin, Gary, Liao, Katherine P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527918/
https://ncbi.nlm.nih.gov/pubmed/31193412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.plabm.2019.e00122
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky